Dapsone
NDC 64980-567, dapsone, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-567
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207165
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-567 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPSONE25 mg/1
Pharmacologic classes
Sulfone [EPC]; Sulfones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-567-01 | 64980056701 | 100 TABLET in 1 BOTTLE (64980-567-01) |
| 64980-567-03 | 64980056703 | 30 TABLET in 1 BOTTLE (64980-567-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e369b26d-219a-4e23-b8d4-f94048d36acdNADAC price for package 64980056701
GET /v1/drugs/nadac/64980056701NADAC price for package 64980056703
GET /v1/drugs/nadac/64980056703
Use it
Look up 64980-567 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-567 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-567. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.